142 related articles for article (PubMed ID: 9654337)
21. Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.
Cass WA; Peters LE; Fletcher AM; Yurek DM
Neurochem Int; 2012 Jan; 60(2):186-91. PubMed ID: 22133428
[TBL] [Abstract][Full Text] [Related]
22. Hydroxyl radical formation following methamphetamine administration to rats.
Kita T; Takahashi M; Kubo K; Wagner GC; Nakashima T
Pharmacol Toxicol; 1999 Sep; 85(3):133-7. PubMed ID: 10522753
[TBL] [Abstract][Full Text] [Related]
23. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
24. Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.
Cass WA; Harned ME; Bailey SL
Brain Res; 2002 May; 938(1-2):29-37. PubMed ID: 12031532
[TBL] [Abstract][Full Text] [Related]
25. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity.
Stephans S; Yamamoto B
Neuroscience; 1996 Jun; 72(3):593-600. PubMed ID: 8861054
[TBL] [Abstract][Full Text] [Related]
26. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
O'Dell SJ; Weihmuller FB; Marshall JF
J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
[TBL] [Abstract][Full Text] [Related]
27. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
O'Dell SJ; Weihmuller FB; Marshall JF
Brain Res; 1991 Nov; 564(2):256-60. PubMed ID: 1810626
[TBL] [Abstract][Full Text] [Related]
28. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
29. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK
Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of post-implantation time on potassium- versus D-amphetamine-evoked dopamine overflow in the striatum of F344 rats.
Purdom MS; Stanford JA; Gerhardt GA
Neurosci Lett; 2003 Sep; 348(2):97-100. PubMed ID: 12902027
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study.
Alfonso M; Durán R; Campos F; Perez-Vences D; Faro LR; Arias B
Neurochem Res; 2003 Oct; 28(10):1487-93. PubMed ID: 14570393
[TBL] [Abstract][Full Text] [Related]
32. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
[TBL] [Abstract][Full Text] [Related]
33. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
34. Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study.
Adachi YU; Watanabe K; Satoh T; Vizi ES
Br J Anaesth; 2001 Jun; 86(6):837-45. PubMed ID: 11573593
[TBL] [Abstract][Full Text] [Related]
35. Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats.
Cass WA; Peters LE
Neurochem Int; 2017 Sep; 108():222-229. PubMed ID: 28390950
[TBL] [Abstract][Full Text] [Related]
36. Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats.
Glick SD; Carlson JN; Baird JL; Maisonneuve IM; Bullock AE
Brain Res; 1988 Nov; 473(1):161-4. PubMed ID: 3208119
[TBL] [Abstract][Full Text] [Related]
37. The role of glutamate in the neurotoxic effects of methamphetamine.
Ohmori T; Abekawa T; Koyama T
Ann N Y Acad Sci; 1996 Oct; 801():315-26. PubMed ID: 8959044
[No Abstract] [Full Text] [Related]
38. Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.
Golembiowska K; Zylewska A
Brain Res; 1998 Sep; 806(2):202-9. PubMed ID: 9739141
[TBL] [Abstract][Full Text] [Related]
39. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
40. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Peters LE; Harned ME; Seroogy KB
Ann N Y Acad Sci; 2006 Aug; 1074():272-81. PubMed ID: 17105923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
